Form 4: Winmark CFO Acquires Shares Through Employee Stock Options
SEC Form 4 Filing
Anthony D. Ishaug, CFO of Winmark Corporation, reports acquisition of shares through employee stock options.
Summary
- Anthony D. Ishaug, the Chief Financial Officer of Winmark Corporation, filed a Form 4 with the SEC.
- The filing reports changes in his beneficial ownership of Winmark securities.
- Ishaug acquired 2,260 shares of common stock through the exercise of employee stock options on June 1, 2024, at a price of $355.90.
- Following the reported transaction, Ishaug directly owns 56,275 shares of Winmark common stock.
- He also holds various employee stock options with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO exercising stock options suggests confidence, but it's a routine filing.
Positives
- The CFO's acquisition of shares through stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice for company insiders and provide transparency regarding their transactions in the company's stock.
Stakeholder Impact
- The CFO's stock transactions may influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/15/2015 | Date of employee stock option grant with exercise price of $80.32, exercisable until 12/15/2024. |
| 06/01/2016 | Date of employee stock option grant with exercise price of $91.93, exercisable until 06/01/2025. |
| 12/14/2016 | Date of employee stock option grant with exercise price of $90.99, exercisable until 12/14/2025. |
| 06/01/2017 | Date of employee stock option grant with exercise price of $98.25, exercisable until 06/01/2026. |
| 12/12/2017 | Date of employee stock option grant with exercise price of $125.5, exercisable until 12/12/2026. |
| 06/01/2018 | Date of employee stock option grant with exercise price of $122.5, exercisable until 06/06/2027. |
| 12/11/2018 | Date of employee stock option grant with exercise price of $134.25, exercisable until 12/11/2027. |
| 06/01/2019 | Date of employee stock option grant with exercise price of $143.2, exercisable until 06/01/2028. |
| 12/11/2019 | Date of employee stock option grant with exercise price of $156, exercisable until 12/11/2028. |
| 06/01/2020 | Date of employee stock option grant with exercise price of $164.84, exercisable until 06/01/2029. |
| 12/16/2020 | Date of employee stock option grant with exercise price of $176.2, exercisable until 12/16/2029. |
| 06/01/2021 | Date of employee stock option grant with exercise price of $143.87, exercisable until 06/01/2030. |
| 12/14/2021 | Date of employee stock option grant with exercise price of $183.87, exercisable until 12/14/2030. |
| 06/01/2022 | Date of employee stock option grant with exercise price of $195.82, exercisable until 06/01/2031. |
| 12/13/2022 | Date of employee stock option grant with exercise price of $261.32, exercisable until 12/13/2031. |
| 06/01/2023 | Date of employee stock option grant with exercise price of $197.8, exercisable until 06/01/2032. |
| 12/12/2023 | Date of employee stock option grant with exercise price of $238.6, exercisable until 12/12/2032. |
| 06/01/2024 | Date of transaction: CFO acquired 2,260 shares through employee stock options at $355.90; Date of employee stock option grant with exercise price of $325.99, exercisable until 06/01/2033. |
| 06/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.